DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

89.58 -0.71 (-0.79%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

FRX $89.58 -0.79%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $89.83
Previous Close $90.29
Daily Range $89.00 - $90.74
52-Week Range $35.22 - $100.88
Market Cap $24.3B
P/E Ratio 155.67
Dividend (Yield) $0.00 (0.0%)
Volume 1,095,921
Average Daily Volume 3,109,626
Current FY EPS $1.34





Forest Laboratories, Inc. (FRX) Description

The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter. Website:

News & Commentary Rss Feed

Here's What You Need to Know About Actavis plc's Acquisition of Forest Labs

Although the price Actavis' paid for Forest Labs is far higher than it would have paid two years ago, Actavis may have still gotten a bargain.

MYL, FRX And ACT, 3 Drugs Stocks Pushing The Industry Lower

Is Now The Time To Buy Ironwood Pharmaceuticals?

Bill Nygren Comments on Forest Laboratories

Regulatory Update from Forest Labs - Analyst Blog

Regulatory Update from Forest Labs - Analyst Blog

Bill Nygren Comments on Forest Laboratories

Buy Actavis - An Attractive Value And Growth Play That Is Also A Top Guru Fund Pick

Pipeline Progress at Prothena - Analyst Blog

US Stock Futures Up; All Eyes On Fed Minutes

Merck KGaA and Auxogyn Collaborate - Analyst Blog

Actavis Up Slightly on Silom Acquisition - Analyst Blog

See More FRX News...

FRX's Top Competitors

FRX $89.58 (-0.79%)
Current stock: FRX
JNJ $98.96 (0.21%)
Current stock: JNJ
NVS $84.67 (0.31%)
Current stock: NVS
RHHBY $36.22 (0.14%)
Current stock: RHHBY